Thread

Moderna said the FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously that the benefits of the vaccine, mRNA-1010, exceed the risks for the prevention of flu in adults 50 through 64 years old, and in adults 65 years of age and older. www.wsj.com/health/pharma/fda-votes-in-fav...Mostrar mais

Anotessa: a vacina mRNA-1010 da Moderna tem voto unânime do comitê da FDA para adultos acima de 50 anos. Parece um avanço interessante pra proteção dessa faixa etária.